Skip to content

Asprosin Level in Individuals with Periodontal Disease

Is THERE a RELATIONSHIP BETWEEN PERIODONTAL CONDITION and ASPROSIN LEVEL in GINGIVAL CREVICULAR FLUID?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06627972
Acronym
ALIGCF
Enrollment
75
Registered
2024-10-04
Start date
2022-01-01
Completion date
2022-08-31
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis, Periodontal Health, Periodontitis

Keywords

gingival crevicular fluid, asprosin hormone, periodontal diseases, tumour necrosis factor alpha

Brief summary

The aim of this study was to investigate the levels of asprosin hormone and tumour necrosis factor alpha (TNF-α) in gingival crevicular fluids and to compare its level with those in saliva and serum in patients with gingivitis and periodontitis.

Detailed description

This study is investigating the level of asprosin hormone in gingival crevicular fluid of patients with periodontal diseases such as gingivitis and periodontitis, and observing the healthy patient in terms of the hormone levels, as well. 75 volunteer patients aged 18-45 years old were included in this study. These patients were divided equally to three groups: Group I; periodontal health, Group II; gingivitis, Group III; periodontitis.The body fluids including serum, saliva and gingival crevicular fluid were collected from this participants according to the proper protocol and their storage was provided under certain conditions. ELISA tests for asprosin and Tumour necrosis factor alpha were made in laboratory. Also, clinical measurements such as plaque index, bleeding on probing, probing pocket depth were recorded at first visit day of the participants. The data were analysed according to the different periodontal conditions, and correlated with asprosin hormone and tumour necrosis factor alpha level in gingival crevicular fluid, serum and saliva.

Interventions

None listed

Sponsors

Mustafa Kemal University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Exclusion criteria

* Those with any systemic disease * Individuals who take medication regularly * Pregnant or lactating women * Individuals with menopause and anthropause * Those who have undergone any periodontal treatment in the last six months * Smokers

Design outcomes

Primary

MeasureTime frameDescription
Asprosin levelDay 1Asprosin level (ng/mL) in gingival crevicular fluid, serum and saliva.

Secondary

MeasureTime frameDescription
TNF-alpha levelsDay 1TNF-alpha level (pg/mL) in gingival crevicular fluid, serum and saliva
Plaque indexDay 1The index was recorded from all participants as numerical between 0-3
bleeding on probingDay 1The bleeding on probing is stated by percentage. the ratio of the number of sites with bleeding gingiva on probing around teeth to total surfaces of all examined teeth
probing pocket depthDay 1The parameters were recorded as mm in all participant. The probing pocket depth is measured from the marginal gingiva to bottom of pocket using a periodontal probe, from six surfaces of each tooth.
body mass indexDay 1the weight and height is combined to report BMI in kg/m2

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026